U.S. Patent No. 5,866,154

2 opinions in this collection construe or address U.S. Patent No. 5,866,154. View the patent on Google Patents.

• February 10, 2022 Fed. Cir. Adapt Pharma Operations v. Teva Pharmaceuticals USA, Inc., No. 20-2106 (Fed. Cir. Feb. 10, 2022) Affirmed
• April 8, 2020 Fed. Cir. Valeant Pharmaceuticals Intl. v. Mylan Pharmaceuticals Inc., No. 18-2097 (Fed. Cir. Apr. 8, 2020) Reversed in Part